Free tool
Cell therapy stocks
We cover 2 companies grouped under the Cell therapy theme. The median market value in the group is $203.16M. Across the group, the median move over the past trading day is +2.15%. Price change over the past year runs from −29.7% to −26.4% across the middle 80 percent of the group, with a median of −28.1%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
2 of 86 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| 219A.T | HEARTSEED INC | 2,435.00 JPY | +48.48% | +34.90% | −30.13% |
| 4584.T | Kidswell Bio Corporation | 179.00 JPY | +29.71% | −15.57% | −26.03% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.